BiotechTube

ASP1707 + itraconazole

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics

Conditions

Pharmacokinetics, DDI (Drug-Drug Interaction), Healthy Subjects

Trial Timeline

Apr 1, 2014 → Jun 1, 2014

NCT ID
NCT02175407

About ASP1707 + itraconazole

ASP1707 + itraconazole is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics. The current trial status is completed. This product is registered under clinical trial identifier NCT02175407. Target conditions include Pharmacokinetics, DDI (Drug-Drug Interaction), Healthy Subjects.

What happened to similar drugs?

5 of 5 similar drugs in Pharmacokinetics were approved

Approved (5) Terminated (0) Active (0)
✅tolterodine + mirabegronAstellas PharmaApproved
✅mirabegronAstellas PharmaApproved
✅Prograf + Tacrolimus HexalNovartisApproved
✅Aripiprazole + Aripiprazole + desvenlafaxine succinate sustained releasePfizerApproved
✅Tamoxifen + Tamoxifen and Desvenlafaxine Succinate Sustained ReleasePfizerApproved

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02175407Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics

See all competitors
ProductCompanyStageHype Score
DFD-29 (Minocycline) Fasting + DFD-29 (Minocycline) Fed + Solodyn (Minocycline) FastingDr. Reddy's LaboratoriesPhase 1
26
DRL_PG + Pegfilgrastim Form A + Pegfilgrastim Form BDr. Reddy's LaboratoriesPhase 1
22
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
16
GP40221 + ozempicGEROPHARMPhase 1
19
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
19
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
16
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
29
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
29
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
29
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
29
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
29
DS-8500aDaiichi SankyoPhase 1
29
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
29
tolterodine + mirabegronAstellas PharmaApproved
43
ASP3652Astellas PharmaPhase 1
29
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
29
YM178 modified release (OCAS) + YM178 immediate release (IR)Astellas PharmaPhase 1
29
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
29
mirabegron + metoprololAstellas PharmaPhase 1
29
ASP015KAstellas PharmaPhase 1
29